abstract |
The present invention diagnoses human anti-IL-13 binding molecules, in particular antibodies, and IL-13 related disorders such as asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin lymphoma Or to methods of using anti-IL-13 antibody molecules in treatment. |